Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 58Neoplasms 52Lung Neoplasms 33Colorectal Neoplasms 28Carcinoma, Non-Small-Cell Lung 25Prostatic Neoplasms 22Melanoma 19Pancreatic Neoplasms 17Ovarian Neoplasms 16Uterine Cervical Neoplasms 14Sarcoma 12Multiple Myeloma 12Lymphoma 11Glioma 11Glioblastoma 11Neoplasm Metastasis 10Leukemia, Myeloid, Acute 10Colonic Neoplasms 10Neoplastic Cells, Circulating 9Hematologic Neoplasms 9Lymphoma, Follicular 8Head and Neck Neoplasms 8Leukemia 7Carcinoma, Hepatocellular 7Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Papillomavirus Infections 6Myelodysplastic Syndromes 6Endometrial Neoplasms 6Disease 6

Interventions

pembrolizumab 7Radiotherapy 3Proton Therapy 3Interleukin-2 3Cyclophosphamide 3spartalizumab 2fludarabine 2Rosuvastatin Calcium 2Paclitaxel 2Ipilimumab 2Immune Checkpoint Inhibitors 2Cetuximab 2Carboplatin 2Blood Specimen Collection 2toripalimab 1tislelizumab 1sotorasib 1peposertib 1pazopanib 1patritumab deruxtecan 1palbociclib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1leronlimab 1lenvatinib 1atezolizumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Solid Tumor, Adult × Blood Specimen Collection × Clear all
NCT02220556 2025-08-08

CTC-CEC-ADN

Institut Curie

Phase NA Completed
360 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT04515043 2021-06-01

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

Invectys

Phase 1 Completed
6 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡